Agenus announces virtual annual shareholders meeting

Lexington, mass.--(business wire)--agenus (nasdaq: agen), a leading immuno-oncology company with a pipeline of immunological agents targeting cancer and infectious disease, today announced that its annual shareholders meeting will begin at 10:30 a.m. et on june 12, 2023 and will be conducted in a virtual format only. registration for attendees will start at 10:15 a.m. et. to participate in the annual shareholders meeting, shareholders should visit http://www.virtualshareholdermeeting.com/agen20.
AGEN Ratings Summary
AGEN Quant Ranking